-
Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes
-
Royalty Pharma to Present at Upcoming Investor Conferences
-
Royalty Pharma to Present at Upcoming Investor Conferences
-
Royalty Pharma to Present at Upcoming Investor Conferences
-
Buffett's Berkshire Hathaway Enters 8 New Stocks, Including Citi and Paramount Global; Adds to Apple and Chevron
-
ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III (DNAC)
-
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III
-
UPDATE: Citi Upgrades Royalty Pharma (RPRX) to Buy
-
Royalty Pharma to Present at Upcoming Investor Conferences
-
Royalty Pharma to Present at Upcoming Investor Conferences
-
Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond
-
Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond
-
Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma plc (RPRX) Prices 17.34M Class A Share Secondary Offering at $42/Sh by Selling Shareholders
-
Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Morgan Stanley profit crushes estimates on trading strength
-
Royalty Pharma (RPRX) Announces 17.3M Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Citi Starts Royalty Pharma (RPRX) at Neutral
-
Royalty Pharma Announces Closing of Initial Public Offering
-
Royalty Pharma Announces Closing of Initial Public Offering
-
Royalty Pharma plc (RPRX) IPO Opens 57% Higher
-
Pre-Open Movers 12/12: (PTI) (RPRX) (GLYC) Higher; (PPHM) (MARA) (CASY) Lower (more...)
-
Pre-Open Stock Movers 04/13: (RPRX) (ACUR) (MDVN) Higher; (CLVS) (VRX) (S) Lower (more...)
-
Pre-Open Stock Movers 01/05: (UNIS) (SWHC) (GPRO) Higher; (MNKD) (ABKA) (VRSN) Lower (more...)
-
StreetInsider.com Pre-Open Movers 02/21: (PRKR) (RPRX) (BRY) Higher; (PAY) (TSLA) (WLT) Lower (more...)
-
StreetInsider.com Pre-Open Movers 02/05: (OPXA) (PLX) (VMED) Higher; (HEB) (YUM) (JCP) Lower (more...)
-
Unusual 11 Mid-Day Movers 09/05: (BONT) (CCRN) (PSTI) Higher; (AUQ) (VRS) (FRAN) Lower
-
Unusual 11 Mid-Day Movers 10/07: RPRX, TWMC, DDSS, TLR Higher; MERX, AAI, SASR, SGMO Lower
-
Morning Movers 10/07: RPRX, DDSS, GTA, CHIP, UCBH, BSMD Higher; MERX, AAI, APPY, SGMO, SIRI Lower
-
Unusual 11 Mid-Day Movers 8/24: FNM, MERC, FRE, WCRX Higher; RPRX, TWI, NRP, VRX Lower
-
Unusual 11 Mid-Day Movers 7/1: OSK, BORL, UIS, SDTH Higher; BEAT, FRPT, RPRX, SPAR Lower

